Jazz Pharmaceuticals JAZZ Effect of exchange rate changes on cash, cash equivalents and restricted cash
Effect of exchange rate changes on cash, cash equivalents and restricted cash at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's effect of exchange rate changes on cash, cash equivalents and restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's effect of exchange rate changes on cash, cash equivalents and restricted cash?
- Jazz Pharmaceuticals (JAZZ) reported effect of exchange rate changes on cash, cash equivalents and restricted cash of -$400K in Q1 2026.
- How has Jazz Pharmaceuticals's effect of exchange rate changes on cash, cash equivalents and restricted cash changed year-over-year?
- Jazz Pharmaceuticals's effect of exchange rate changes on cash, cash equivalents and restricted cash decreased by 123.5% year-over-year, from $1.7M to -$400K.
- What does effect of exchange rate changes on cash, cash equivalents and restricted cash mean?
- Gain or loss in cash value due to changes in currency exchange rates.
- How do you interpret effect of exchange rate changes on cash, cash equivalents and restricted cash?
- Reflects exposure to international markets; significant values indicate high currency volatility or large foreign cash holdings.
- How does effect of exchange rate changes on cash, cash equivalents and restricted cash compare across companies?
- Standard adjustment for multinational corporations.